Discriminative stimulus properties of S32504, a novel D₃/D₂ receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D₂ but not D₃ receptors

By Millan Mark   Iob Loretta   Péglion Jean-Louis   Dekeyne Anne  

Psychopharmacology, Vol. 191, Iss. 3, 2007-04 ,pp. : 767-782

Springer Publishing Company

Access to resources Recommend Favorite

Neuropharmacological assessment of potential dopamine D 4 receptor-selective radioligands

By Kula N.S.   Tarazi F.I.   Baldessarini R.J.   Xu L.   Bakthavachalam V.   Pounds S.   True C.D.  

European Journal of Pharmacology, Vol. 367, Iss. 1, 1999-02 ,pp. : 139-142

Elsevier

Access to resources Recommend Favorite

Selective dopamine D₃ receptor antagonists. A decade of progress: 1997 – 2007

By Micheli Fabrizio   Heidbreder Christian  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 8, 2008-08 ,pp. : 821-840

Informa Healthcare

Access to resources Recommend Favorite

Selective dopamine D4 receptor antagonists

By Sanner M.A.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 4, 1998-04 ,pp. : 383-393

Informa Healthcare

Access to resources Recommend Favorite

Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines

By Neumeyer J.L.   Kula N.S.   Bergman J.   Baldessarini R.J.  

European Journal of Pharmacology, Vol. 474, Iss. 2, 2003-08 ,pp. : 137-140

Elsevier

Access to resources Recommend Favorite